Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren's Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial - Institut Brestois du Numérique et des Mathématiques
Article Dans Une Revue Arthritis Care & Research = Arthritis Care and Research Année : 2017

Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren's Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial

Jean-Marie Berthelot
Xavier Puéchal
Jean Sibilia
  • Fonction : Auteur
  • PersonId : 948651
Laurent Chiche
Éric Hachulla
Pierre-Yves Hatron
  • Fonction : Auteur
  • PersonId : 948225
Vincent Goëb
Gilles Hayem
Philippe Saliou
Jacques Olivier Pers Dds

Résumé

To identify the principal determinants of health-related quality-of-life [HR-QoL] impairment in patients with active primary Sjögren's syndrome [pSS] participating in a large therapeutic trial [TEARS]. At the inclusion visit for the TEARS trial, 120 patients with active pSS completed the Short Form survey 36 [SF36], a validated HR-QoL assessment tool. Univariate then multivariate linear regression analyses were used to assess associations linking SF36 physical and mental components to demographic data, patient-reported outcomes [symptom intensity assessments for dryness, pain and fatigue, including the EULAR SS Patient Reported Index (ESSPRI)], objective measures of dryness and autoimmunity, and physician evaluation of systemic activity [using the EULAR SS Disease Activity Index (ESSDAI)]. SF36 scores indicated marked HR-QoL impairments in our population with active pSS. Approximately 1/3 of the patients had low, moderate and high systemic activity according to the ESSDAI. ESSPRI and ESSDAI scores were moderately but significantly correlated. The factors most strongly associated with HR-QoL impairment were patient-reported symptoms, best assessed using the ESSPRI, with pain and ocular dryness intensity showing independent associations with HR-QoL. Conversely, systemic activity level was not associated with HR-QoL impairment in multivariate analyses, even in the patient subset with ESSDAI values indicating moderate-to-high systemic activity. The cardinal symptoms of pSS (dryness, pain and fatigue, best assessed using the ESSPRI) are stronger predictors of HR-QoL impairment than systemic involvement (assessed by the ESSDAI), and should be used as endpoints in future therapeutic trials focusing on patients' well-being. New consensual and data-driven response criteria are needed for pSS studies. This article is protected by copyright. All rights reserved.

Domaines

Immunologie
Fichier principal
Vignette du fichier
cornec2016.pdf (801.64 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01352119 , version 1 (29-11-2024)

Identifiants

Citer

Divi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, Jean-Marie Berthelot, et al.. Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren's Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial. Arthritis Care & Research = Arthritis Care and Research, 2017, 69 (4), pp.528-535. ⟨10.1002/acr.22974⟩. ⟨hal-01352119⟩
257 Consultations
0 Téléchargements

Altmetric

Partager

More